Predictive Performance of Echocardiographic Parameters for Cardiovascular Events Among Elderly Treated Hypertensive

Enayet K Chowdhury1, Garry L R Jennings2, Elizabeth Dewar2

  • 1Centre of Cardiovascular Research & Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia; enayet.chowdhury@monash.edu.

Insights

Left ventricular hypertrophy (LVH) assessed by echocardiography predicts cardiovascular events in elderly hypertensive patients. The LVH-BSA(115/95) definition reliably identifies high-risk individuals for future cardiovascular outcomes.

Area of Science:

  • Cardiology
  • Geriatrics
  • Hypertension Research

Background:

  • Hypertension causes cardiac changes detectable by echocardiography.
  • Assessing left ventricular hypertrophy (LVH) is crucial for predicting cardiovascular risk in hypertensive patients.
  • This study focuses on elderly hypertensive individuals without heart failure.

Purpose of the Study:

  • To evaluate the predictive performance of echocardiographic parameters for cardiovascular outcomes.
  • To specifically assess the role of left ventricular hypertrophy (LVH) in elderly hypertensive patients.
  • To compare different LVH definitions for their predictive accuracy.

Main Methods:

  • Utilized data from the Second Australian National Blood Pressure trial (LVH substudy).
  • Echocardiograms were performed at baseline in 666 participants aged ≥65 years.
  • Defined LVH using specific thresholds for left ventricular mass (LVM) indexed to body surface area (BSA) or height(2.7).

Main Results:

  • LVH prevalence varied from 33% to 70% based on definition.
  • Only LVH-BSA(115/95) significantly predicted both short- and long-term cardiovascular outcomes after risk factor adjustment.
  • Patients with LVH-BSA(115/95) had a doubled risk of cardiovascular events (short-term) and fatal events (long-term).

Conclusions:

  • Echocardiographic LVH assessment in elderly hypertensives is definition-dependent.
  • The LVH-BSA(115/95) definition is a reliable predictor of future cardiovascular events in this population.
  • This finding aids in risk stratification for elderly hypertensive patients.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
709
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
891
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
312
Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
827
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
643
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
310